Corcept Therapeutics Incorporated (CORT)
NASDAQ: CORT · Real-Time Price · USD
35.70
-0.08 (-0.22%)
At close: Feb 27, 2026, 4:00 PM EST
35.75
+0.05 (0.14%)
After-hours: Feb 27, 2026, 7:52 PM EST
Corcept Therapeutics Stock Forecast
Stock Price Forecast
The 5 analysts that cover Corcept Therapeutics stock have a consensus rating of "Buy" and an average price target of $105.2, which forecasts a 194.68% increase in the stock price over the next year. The lowest target is $60 and the highest is $150.
Price Target: $105.2 (+194.68%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Corcept Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Sep '25 | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 1 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 5 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $67 → $60 | Strong Buy | Maintains | $67 → $60 | +68.07% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $105 → $67 | Strong Buy | Maintains | $105 → $67 | +87.68% | Feb 20, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $99 → $100 | Strong Buy | Maintains | $99 → $100 | +180.11% | Jan 23, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $105 | Strong Buy | Maintains | $90 → $105 | +194.12% | Jan 23, 2026 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $140 → $99 | Strong Buy | Maintains | $140 → $99 | +177.31% | Jan 2, 2026 |
Financial Forecast
Revenue This Year
994.62M
from 761.41M
Increased by 30.63%
Revenue Next Year
1.31B
from 994.62M
Increased by 31.61%
EPS This Year
0.62
from 0.82
Decreased by -24.54%
EPS Next Year
3.14
from 0.62
Increased by 406.87%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.1B | 1.8B | |||
| Avg | 994.6M | 1.3B | |||
| Low | 826.1M | 934.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 49.9% | 77.8% | |||
| Avg | 30.6% | 31.6% | |||
| Low | 8.5% | -6.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 1.50 | 4.20 | |||
| Avg | 0.62 | 3.14 | |||
| Low | -0.91 | 2.46 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 83.1% | 578.7% | |||
| Avg | -24.5% | 406.9% | |||
| Low | - | 297.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.